Your browser doesn't support javascript.
loading
Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front.
Ozaki-Honda, Yuu; Seki, Sachiko; Fujiwara, Mutsunori; Matsuura, Masaaki; Fujita, Shuichi; Ikeda, Hisazumi; Umeda, Masahiro; Ayuse, Takao; Ikeda, Tohru.
Afiliação
  • Ozaki-Honda Y; Department of Oral Pathology and Bone Metabolism, Nagasaki University Graduate School of Biomedical Sciences, 1-5-8 Sakamoto, Nagasaki, Japan.
  • Seki S; Department of Clinical Physiology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Fujiwara M; Department of Oral Pathology and Bone Metabolism, Nagasaki University Graduate School of Biomedical Sciences, 1-5-8 Sakamoto, Nagasaki, Japan.
  • Matsuura M; Department of Clinical Pathology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Fujita S; Bioinformatics Group, Genome Center, Japanese Foundation for Cancer Research, Japan, and Graduate School of Public Health, Teikyo University, Tokyo, Japan.
  • Ikeda H; Department of Oral Pathology and Bone Metabolism, Nagasaki University Graduate School of Biomedical Sciences, 1-5-8 Sakamoto, Nagasaki, Japan.
  • Umeda M; Department of Regenerative Oral Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Ayuse T; Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Ikeda T; Department of Clinical Physiology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Cancer Microenviron ; 10(1-3): 87-94, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29098659
Epithelial-mesenchymal transition (EMT) is a significant process in the invasion and metastasis of cancers including oral squamous cell carcinoma (OSCC), and the cadherin switch has been identified as one of the hallmarks of EMT. The aim of the present study was to evaluate the significance of the cadherin switch in the prognosis of OSCC and generate a model for prognostic predictions. Seventy-six biopsy and/or initial surgical specimens from OSCC patients were immunohistochemically analyzed for the expression of E-cadherin and N-cadherin in either overall OSCC cells in tumor nests or in OSCC cells at the invasive front. Among 76 OSCC cases, overall OSCC cells in tumor nests were negative for the expression of E-cadherin in 10 cases and positive for that of N-cadherin in 53 cases. Among 10 cases negative for the expression of E-cadherin, 4 cases were positive for that of N-cadherin. In OSCC cells at the invasive front, the expression of E-cadherin was negative in 62 cases, while that of N-cadherin was positive in 39 cases. Among 62 cases negative for the expression of E-cadherin, 33 cases were positive for that of N-cadherin. A logistic regression analysis showed that a model using the evaluation of N-cadherin expression in overall OSCC cells in tumor nests with a cut-off point of 70 years old was the best fit model. These results suggest that N-cadherin has significant value in prognostic predictions for OSCC patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Microenviron Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Microenviron Ano de publicação: 2017 Tipo de documento: Article